Recent News Stories

Tue, Aug 19, 2014 - 08:30
Learn more about Christine Rodriguez, NVHR's new Public Policy Manager
Mon, Aug 18, 2014 - 12:44
NVHR has developed a new fact sheet on why providers should screen for hepatitis C, even with challenges in treatment access.
Wed, Aug 06, 2014 - 08:46
Please sign a community statement urging stakeholders to end the hepatitis C treatment access crisis!
Fri, Jul 04, 2014 - 16:20
Take a few minutes to make two important phone calls to your U.S. Senators!
 
 
 
 

Recent Posts

Tue, Aug 19, 2014 - 09:08
NVHR has created a fact sheet about The Viral Hepatitis Testing Act of 2014 (S. 2538). The legislation would authorize $80 million over three years for a comprehensive national system – an enhancement and strengthening of existing public health programs – for surveillance, education, testing, and linkage to care for HBV and HCV, to prevent transmission, morbidity, and mortality from viral hepatitis-related chronic liver disease and liver cancer.
Tue, Aug 19, 2014 - 09:07
NVHR has developed a fact sheet about The Viral Hepatitis Testing Act of 2013 (H.R. 3723). The legislation would authorize $80 million over three years for a comprehensive national system – an enhancement and strengthening of existing public health programs – for surveillance, education, testing, and linkage to care for HBV and HCV, to prevent transmission, morbidity, and mortality from viral hepatitis-related chronic liver disease and liver cancer.
Tue, Jul 29, 2014 - 14:58
People with chronic hepatitis C who are using methadone or buprenorphine to manage opiate addiction can be safely and effectively treated with AbbVie's 3D all-oral direct-acting antiviral regimen plus ribavirin, resulting in a 97% cure rate, according to a report this week at the 20th International AIDS Conference in Melbourne.
Tue, Jul 29, 2014 - 14:56
The hepatitis C virus (HCV) World Community Advisory Board (CAB) grew from an international AIDS activist movement. The objectives of the meeting were threefold: To provide a forum for leading activists to learn about developments in HCV treatment and access barriers; To find common advocacy strategies; and To meet with pharmaceutical companies about their plans for low- and middle-income countries (LMICs).
Tue, Jul 29, 2014 - 14:48
The importance of integrating people who inject drugs into HCV treatment programs. Arguments from a public health and human rights perspective. This document develops core arguments for why it is relevant, feasible, and indeed crucial to include people who inject drugs in national treatment guidelines and programs for chronic HCV infection – from both public health and human rights perspectives.
 
 
 
 
member logos
Banner2
Banner1
member logos
member logos
taskforce
Asoicacion Puertorriquenos en Marche (APM)
slide 12